Leuven, Belgium - May 31, 2012

Precision-Drive Articulating Surgical System

Only one year after the first operation with Kymerax™ was successfully performed in Europe, Terumo Europe N.V. announced today that the precision-drive articulating surgical system will be featured in a scientific session during the Challenges in Laparoscopy & Robotics congress held June 7 – 9, 2012 in Rome, Italy.

The urological procedure will be performed by Prof. Dr. Günter Janetschek, Director of the Department of Urology and Andrology at Paracelsus Medical University Salzburg, Austria. A laparoscopic radical prostatectomy (LRP) will be performed on Saturday, June 9.

“Kymerax handheld articulating instruments for standard laparoscopy offer 6 degrees of freedom. With Kymerax, the limitations of straight instruments can be overcome,” said Prof. Günter Janetschek. “We have used them in our daily clinical routine for 1 year.”

About the Kymerax™ System

The Kymerax™ technology, which received CE certification in 2011, features advances in essential instrument components to offer improved efficiency with a comparable safety profile. Kymerax™ enables the surgeon to manipulate motorized handle controls to angulate and roll the instrument tip in multiple directions, facilitating the approach of tissues and organs from various angles.

With its ergonomic design, Kymerax™ could also potentially mean less fatigue and better ergonomic positioning for surgeons. Kymerax™ is suited for laparoscopic procedures in gynecology, urology and gastrointestinal surgery and provides an alternative approach to minimally invasive surgery.

For more information, please visit: www.kymerax.com

-more-

About Terumo

Tokyo-based Terumo Corporation is one of the world’s leading medical device manufacturers with $4 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures, and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use.

Terumo contributes to society by providing valued products and services to the healthcare market and by responding to the needs of healthcare providers and the people they serve. Terumo Corporation’s shares are listed on the first section of the Tokyo Stock Exchange and is a component of the Nikkei, Japan’s leading stock index.

For more information, contact Melanie Hubbs, Terumo Europe N.V., +49 6196 8023 551

# # #